The CDC advisory panel, ACIP, has voted and declared that the first wave of vaccines should go to the front line healthcare workers and elderly residents in long term care facilities as part of Phase1a. The decision was not unanimous.
All News
Article
Article
Dr. Kevin Winthrop reviews all things COVID-related including abstract L01 from the 2020 ACR Convergence, steroids and DMARDs, vaccination status - and how long this pandemic will last.
#FDA, Summary of Dr. Aron Halls CDC presentation and updates on COVID-19 https://t.co/DUAftAKq0R
#FDA hearing on Covid vaccines - shows current seroprevalence by state, currently < 10% seroprevalence with higher rates in children and young adults https://t.co/8eG5cKQBiA
Is COVID19 infection bad for rheumatic disease patients? Dr. Jeff Curtis ( @RADoctor) reviews abstract L01 presented at #ACR20.
https://t.co/hm7geJKzNt https://t.co/gAY6k7ywLw
Check out Dr. Kathyrn Dao's blog experience. A rheumatology researcher signs up for the COVID-19 vaccine! https://t.co/B9Wsvo7DJH
How COVID Changed Work: Drs. Rachel Tate, Cassie Calabrese and Mary Hinojos Mamut #ACR20
https://t.co/jyM8NPicZF https://t.co/6zA7Kmgzwi
Worth the read!
My Experience as a COVID19 Vaccine Trial Participant by Dr. Kathryn Dao ( @KDAO2011)
https://t.co/ILfXLUL8IZ https://t.co/7parTGPllu
Timely video on COVID 19 and Rheumatic Disease with Dr. Jeffrey Sparks ( @jeffsparks) #acr20
https://t.co/5Qg3HRkQyW
Timely video on COVID 19 and Rheumatic Disease with Dr. Jeffrey Sparks ( @jeffsparks) #acr20
https://t.co/5Qg3HRkQyW https://t.co/x0iQ6XX3eJ
#BestACR20Tweets
RT @doctorRBC : Tocilizumab NOT effective in preventing mechanical ventilation or death in moderately ill COVID-19 pts.
Double-blind, Placebo, RCT (n=243)
@RheumNow #ACR20 Abs#L07 #ACRbest https://t.co/Gi5FpodeKf https://t.co/bTk8n7dNni
Video:COVID and Rheumatic Disease Patients with Dr. Kevin Winthrop #ACR20
https://t.co/VHIibPNDXG https://t.co/0OVIXzX6su
#BestACR20Tweets
RT @synovialjoints : About half (51%) of patients from the FORWARD registry in the US had at least one telehealth appointment during COVID-19 pandemic and most were satisfied with the appointment @RheumNow #ACR20 Abstr#1962 https://t.co/PEiucSItZq https://t.co/6vzIlQWjOP
#BestACR20Tweets
RT @synovialjoints : About half (51%) of patients from the FORWARD registry in the US had at least one telehealth appointment during COVID-19 pandemic and most were satisfied with the appointment #ACR20 Abstr#1962 https://t.co/PEiucSItZq https://t.co/Z2qRaWDRaN
Six Things Rheumatologists Need to Know About COVID-19 by Dr. Rachel Tate ( @uptoTate) #ACR20
https://t.co/RUWDexA3Qc https://t.co/Psd8V60XxO
COVID: DMARDs, Steroids, a Vaccine - and how long will this continue? #ACR20
https://t.co/UHKxNcpojh https://t.co/0rvOmEVrK7
A Convergence of Ideas: COVID19 and ACR by Dr. Kathryn Dao (@KDAO2011) #ACR20 https://t.co/95Y3ilCwyq https://t.co/Oje9vcbHnt
Watch our video titled "Outcomes for Rheumatic Disease Patients with COVID-19" with Dr Kathryn Dao ( @KDAO2011) #ACR20
https://t.co/771RLB0pqA https://t.co/glr98MQHac
Telemedicine Studies: A Trainee’s Perspective by Mrinalini Dey ( @DrMiniDey ) COVID-19 has shifted face to face to consultations--an important change in rheumatology practice. #ACR20 https://t.co/IzvyeFC8w8 https://t.co/SIQxfuUuEk
Moderna mRNA-1273 vaccine, developed for COVID-19, yielded 94.5% efficacy in early results of the phase 3 COVE trial. 90 who were COVID-19 pos were in a placebo group and that 5 patients were in the mRNA-1273 vaccine group. https://t.co/9245wj3kph
